Assessment of Montelukast, Doxofylline, and Tiotropium With Budesonide for the Treatment of Asthma: Which Is the Best Among the Second-line Treatment? A Randomized Trial-Reference-Cited by-同舟云学术

Assessment of Montelukast, Doxofylline, and Tiotropium With Budesonide for the Treatment of Asthma: Which Is the Best Among the Second-line Treatment? A Randomized Trial

Published:2015-02 Issue:2 Volume:37 Page:418-426
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Rajanandh Muhasaparur Ganesan,Nageswari Arcot D.,Ilango Kaliappan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference23 articles.

1. Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline and tiotropium with budesonide: a randomized controlled study;Rajanandh;Clin Ther,2014

2. Asthma outcomes: quality of life;Wilson;J Allergy Clin Immunol,2012

3. Comparison between formoterol 12 mg b.i.d. and on demand salbutamol in moderate persistent asthma;Molimard;Respir Med,2001

4. Summary of the 2008 BTS/SIGN British Guideline on the management of asthma;Levy;Prim Care Respir J,2009

5. Influence of demographic status on pulmonary function, quality of life and symptom scores in patients with mild to moderate persistent asthma;Rajanandh;J Exp Clin Med,2014

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement;Expert Opinion on Pharmacotherapy;2024-05-23

2. Doxofylline as a steroid-sparing treatment in Mexican children with asthma;Journal of Asthma;2023-12-28

3. Pediatric Asthma: Where Has Montelukast Gone?;Applied Sciences;2023-03-24

4. Comparison of National and Global Asthma Management Guiding Documents;Respiratory Care;2022-12-24

5. Doxofylline for Pediatric Asthma Steps 1–4. Pediatric Asthma: New Role for an Old Drug;Frontiers in Pediatrics;2022-06-22